Drawn from Steve Gorin’s 4th quarter 2021 newsletter, this course discusses certain recent IRS developments in tax practice, a recent case on using life insurance to fund buy-sell agreements, and recent cases on loan guarantees.
IRS developments include guidance extending electronic signatures (including what is permitted), describing the effect of superseding returns, and reliance on FAQs the IRS posts. We will also briefly mention advocacy relating to incorrect IRS penalty notices.
Then we will turn to planning in light of a September case increasing the value of a business interest due to life insurance the company received on the insured’s death that the company was required to use to buy the business interest. First, we will review various income tax issues relating to using life insurance. Next, we will discuss the choice between a purchase by the business entity (a redemption) and a purchase by the remaining shareholders (a cross purchase). We will then discuss the estate tax effect of buy-sell agreements on valuing the decedent’s business interest and describe the risks that redemptions have, describing the leading cases on that topic. We will conclude that topic with using a life insurance LLC to fund a cross purchase.
Finally, we will discuss using loan guarantees to provide substance to loans to borrowers that have modest net worth. We will review the consequences of loan guarantees and some recent income tax developments that generally inform guarantees and loans, with a very brief reference to new regulations regarding the switch from LIBOR.
The live presentation of this webinar was approved for 1.5 hours of general CLE credit in California and Illinois and 1.8 hours of general CLE credit in Missouri. The webinar was also approved for 1.5 hours of general-experienced and general-transitional CLE in New York. 1.5 hours of general CLE credit is pending in Texas. If you are interested in receiving credit for watching the recorded presentation, please click here.
January 25, 2022
Although we would like to hear from you, we cannot represent you until we know that doing so will not create a conflict of interest. Also, we cannot treat unsolicited information as confidential. Accordingly, please do not send us any information about any matter that may involve you until you receive a written statement from us that we represent you (an â€˜engagement letterâ€™).
By clicking the â€˜ACCEPTâ€™ button, you agree that we may review any information you transmit to us. You recognize that our review of your information, even if you submitted it in a good faith effort to retain us, and, further, even if you consider it confidential, does not preclude us from representing another client directly adverse to you, even in a matter where that information could and will be used against you. Please click the â€˜ACCEPTâ€™ button if you understand and accept the foregoing statement and wish to proceed.